Spies et al
What the Clinical Evidence Honestly Does Not Yet Show Intellectual honesty requires stating plainly what the research base does not support: No randomised controlled trial exists for the KLOW stack as a combined formulation
[1] [13] When B12 levels are borderline or clinical suspicion remains high despite normal B12, additional tests include: Holotranscobalamin (active B12) , which may be more sensitive in early or borderline deficiency Methylmalonic acid (MMA) and homocysteine levels, which become elevated in functional B12 deficiency (note that MMA is also elevated in renal impairment, and homocysteine rises in folate and B6 deficiency) Full blood count to identify macrocytic anaemia (elevated mean cell volume) Blood film examination may show hypersegmented neutrophils and megaloblastic changes Serum folate should be checked concurrently, as deficiencies often coexist Investigating the underlying cause is essential for appropriate management
High ROS levels not only damage DNA, proteins and lipids to induce genome instability and activate NF-B, PI3K, HIF-1, and MAPK which contributes to carcinogenesis (116), but also result in T2DM (117, 118)
Scientific Research & Evidence
10.1007/s002280050140 Eur J Clin Pharmacol